Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneGoCell offers CLIA/CAP, GMP/GLP-compliant next-generation sequencing and flow cytometry solutions for the gene and cell therapy industry. Their core offerings include genome editing verification, single clone genotyping, custom NGS assays, with rapid turnaround times—90% of results delivered within one week. They do not develop therapeutic drugs but provide essential analytical support to researchers from preclinical through clinical trial stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneGoCell.